Platelet activating factor receptor-deficient mice present delayed interferon-γ upregulation and high susceptibility to Leishmania amazonensis infection

Microbes and Infection

Volumn 8, Issue 11, 2006, Pages 2569-2577

  Santiago, Helton C ^a   Braga Pires, Maíra Faria ^a   Souza, Daniele G ^a   Roffê, Ester ^a   Côrtes, Denise F ^a   Tafuri, Wagner L ^a   Teixeira, Mauro M ^a   Vieira, Leda Q ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Cytokines; Lipid mediators; Parasitic protozoan; Th1 Th2 cells

Indexed keywords

ANTIBODY; ARGINASE; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; MESSENGER RNA; RANTES; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; FEMALE; IMMUNE RESPONSE; INFECTION SENSITIVITY; LEISHMANIA; LEISHMANIASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; WILD TYPE;

ANIMALS; ANTIBODIES, PROTOZOAN; ARGINASE; CHEMOKINES, CC; DISEASE MODELS, ANIMAL; DISEASE SUSCEPTIBILITY; GENE EXPRESSION; HISTOCYTOCHEMISTRY; IMMUNOGLOBULIN G; INTERFERON TYPE II; INTERLEUKIN-10; LEISHMANIA MEXICANA; LEISHMANIASIS, CUTANEOUS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NITRIC OXIDE SYNTHASE TYPE II; PLATELET MEMBRANE GLYCOPROTEINS; RECEPTORS, G-PROTEIN-COUPLED; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

LEISHMANIA AMAZONENSIS; MURINAE; PROTOZOA;

EID: 33750315763     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2006.06.011     Document Type: Article

References (30)

1. Sacks D., and Noben-Trauth N. The immunology of susceptibility and resistance to Leishmania major in mice. Nat. Rev. Immunol. 2 (2002) 845-858
2. Afonso L.C., and Scott P. Immune responses associated with susceptibility of C57BL/10 mice to Leishmania amazonensis. Infect. Immun. 61 (1993) 2952-2959
3. Buxbaum L.U., Uzonna J.E., Goldschmidt M.H., and Scott P. Control of New World cutaneous leishmaniasis is IL-12 independent but STAT4 dependent. Eur. J. Immunol. 32 (2002) 3206-3215
4. Ishii S., and Shimizu T. Platelet-activating factor (PAF) receptor and genetically engineered PAF receptor mutant mice. Prog. Lipid Res. 39 (2000) 41-82
5. Marrache A.M., Gobeil Jr. F., Bernier S.G., Stankova J., Rola-Pleszczynski M., Choufani S., Bkaily G., Bourdeau A., Sirois M.G., Vazquez-Tello A., Fan L., Joyal J.S., Filep J.G., Varma D.R., Ribeiro-Da-Silva A., and Chemtob S. Proinflammatory gene induction by platelet-activating factor mediated via its cognate nuclear receptor. J. Immunol. 169 (2002) 6474-6481
6. Talvani A., Santana G., Barcelos L.S., Ishii S., Shimizu T., Romanha A.J., Silva J.S., Soares M.B., and Teixeira M.M. Experimental Trypanosoma cruzi infection in platelet-activating factor receptor-deficient mice. Microbes Infect. 5 (2003) 789-796
7. Aliberti J.C., Machado F.S., Gazzinelli R.T., Teixeira M.M., and Silva J.S. Platelet-activating factor induces nitric oxide synthesis in Trypanosoma cruzi-infected macrophages and mediates resistance to parasite infection in mice. Infect. Immun. 67 (1999) 2810-2814
8. Choi J.H., Ko H.M., Kim J.W., Lee H.K., Han S.S., Chun S.B., and Im S.Y. Platelet-activating factor-induced early activation of NF-kappa B plays a crucial role for organ clearance of Candida albicans. J. Immunol. 166 (2001) 5139-5144
9. Lonardoni M.V., Barbieri L.C., Russo M., and Jancar S. Modulation of Leishmania (L.) amazonensis growth in cultured mouse macrophages by prostaglandins and platelet-activating factors. Mediators Inflamm. 3 (1994) 137-141
10. Lonardoni M.V., Russo M., and Jancar S. Essential role of platelet-activating factor in control of Leishmania (Leishmania) amazonensis infection. Infect. Immun. 68 (2000) 6355-6361
11. Ishii S., Kuwaki T., Nagase T., Maki K., Tashiro F., Sunaga S., Cao W.H., Kume K., Fukuchi Y., Ikuta K., Miyazaki J., Kumada M., and Shimizu T. Impaired anaphylactic responses with intact sensitivity to endotoxin in mice lacking a platelet-activating factor receptor. J. Exp. Med. 187 (1998) 1779-1788
12. Oliveira M.A., Santiago H.C., Lisboa C.R., Ceravollo I.P., Trinchieri G., Gazzinelli R.T., and Vieira L.Q. Leishmania sp: comparative study with Toxoplasma gondii and Trypanosoma cruzi in their ability to initialize IL-12 and IFN-gamma synthesis. Exp. Parasitol. 95 (2000) 96-105
13. dos Santos P.V., Roffe E., Santiago H.C., Torres R.A., Marino A.P., Paiva C.N., Silva A.A., Gazzinelli R.T., and Lannes-Vieira J. Prevalence of CD8(+)alpha beta T cells in Trypanosoma cruzi-elicited myocarditis is associated with acquisition of CD62L(Low)LFA-1(High)VLA-4(High) activation phenotype and expression of IFN-gamma-inducible adhesion and chemoattractant molecules. Microbes Infect. 3 (2001) 971-984
14. Padigel U.M., Alexander J., and Farrell J.P. The role of interleukin-10 in susceptibility of BALB/c mice to infection with Leishmania mexicana and Leishmania amazonensis. J. Immunol. 171 (2003) 3705-3710
15. Kima P.E., Constant S.L., Hannum L., Colmenares M., Lee K.S., Haberman A.M., Shlomchik M.J., and McMahon-Pratt D. Internalization of Leishmania mexicana complex amastigotes via the Fc receptor is required to sustain infection in murine cutaneous leishmaniasis. J. Exp. Med. 191 (2000) 1063-1068
16. Lima G.M., Puel A., Decreusefond C., Bouthillier Y., Mevel J.C., Abrahamsohn I.A., and Mouton D. Susceptibility and resistance to Leishmania amazonensis in H-2q syngeneic high and low antibody responder mice (Biozzi mice). Scand. J. Immunol. 48 (1998) 144-151
17. Soares A.C., Pinho V.S., Souza D.G., Shimizu T., Ishii S., Nicoli J.R., and Teixeira M.M. Role of the platelet-activating factor (PAF) receptor during pulmonary infection with gram negative bacteria. Br. J. Pharmacol. 137 (2002) 621-628
18. Androulakis N., Durand H., Ninio E., and Tsoukatos D.C. Molecular and mechanistic characterization of platelet-activating factor-like bioactivity produced upon LDL oxidation. J. Lipid Res. 46 (2005) 1923-1932
19. Fei G.Z., Huang Y.H., Swedenborg J., and Frostegard J. Oxidised LDL modulates immune-activation by an IL-12 dependent mechanism. Atherosclerosis 169 (2003) 77-85
20. + regulatory T cells restrain pathogenic responses during Leishmania amazonensis infection. J. Immunol. 174 (2005) 7147-7153
21. Campbell K., Diao H., Ji J., and Soong L. DNA immunization with the gene encoding P4 nuclease of Leishmania amazonensis protects mice against cutaneous Leishmaniasis. Infect. Immun. 71 (2003) 6270-6278
22. Frostegard J., Huang Y.H., Ronnelid J., and Schafer-Elinder L. Platelet-activating factor and oxidized LDL induce immune activation by a common mechanism. Arterioscler. Thromb. Vasc. Biol. 17 (1997) 963-968
23. Belosevic M., Finbloom D.S., Van Der Meide P.H., Slayter M.V., and Nacy C.A. Administration of monoclonal anti-IFN-gamma antibodies in vivo abrogates natural resistance of C3H/HeN mice to infection with Leishmania major. J. Immunol. 143 (1989) 266-274
24. Santiago H.C., Oliveira C.F., Santiago L., Ferraz F.O., Souza D.G., de-Freitas L.A., Afonso L.C., Teixeira M.M., Gazzinelli R.T., and Vieira L.Q. Involvement of the chemokine RANTES (CCL5) in resistance to experimental infection with Leishmania major. Infect. Immun. 72 (2004) 4918-4923
25. Villalta F., Zhang Y., Bibb K.E., Kappes J.C., and Lima M.F. The cysteine-cysteine family of chemokines RANTES, MIP-1alpha, and MIP-1beta induce trypanocidal activity in human macrophages via nitric oxide. Infect. Immun. 66 (1998) 4690-4695
26. Maruoka S., Hashimoto S., Gon Y., Takeshita I., and Horie T. PAF-induced RANTES production by human airway smooth muscle cells requires both p38 MAP kinase and Erk. Am. J. Respir. Crit. Care Med. 161 (2000) 922-929
27. Balestieri F.M., Queiroz A.R., Scavone C., Costa V.M., Barral-Netto M., and Abrahamsohn I.A. Leishmania (L.) amazonensis-induced inhibition of nitric oxide synthesis in host macrophages. Microbes Infect. 4 (2002) 23-29
28. Iniesta V., Gomez-Nieto L.C., Molano I., Mohedano A., Carcelen J., Miron C., Alonso C., and Corraliza I. Arginase I induction in macrophages, triggered by Th2-type cytokines, supports the growth of intracellular Leishmania parasites. Parasite Immunol. 24 (2002) 113-118
29. Iniesta V., Gomez-Nieto L.C., and Corraliza I. The inhibition of arginase by N(omega)-hydroxy-l-arginine controls the growth of Leishmania inside macrophages. J. Exp. Med. 193 (2001) 777-784
30. Corraliza I.M., Soler G., Eichmann K., and Modolell M. Arginase induction by suppressors of nitric oxide synthesis (IL-4, IL-10 and PGE2) in murine bone-marrow-derived macrophages. Biochem. Biophys. Res. Commun. 206 (1995) 667-673